FDA guidelines would expand access to unapproved drugs

12/11/2006 | NYTimes.com

The FDA proposed new guidelines for releasing unapproved drugs for patients who have no other options for treating life-threatening conditions. The proposed guidelines say drugs could be available during all stages of development, including initial, Phase I testing.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC